BMI View: A deteriorating macroeconomic outlook for the country in 2013 and 2014 will see the
consumption of medicines and healthcare services slow in the short-term. Additionally, ongoing
depreciation of the South African Rand against hard currencies will have a nega ..."
BMI View: This quarter has seen local generic drug maker Adcock Ingram receive two further non-binding proposals for the company's takeover, highlighting the long-term commercial opportunities represented by the South African and regional generic drug markets. BMI believes increa ..."
BMI View: South Africa is the best investment opportunity for multinational drugmakers seeking to enter
the African market. The country currently boasts the largest medicines market on the continent by value,
with a double-digit increase in expenditure expected in the medium an ..."
BMI View: The Ministry of Health announced this quarter it would increase 2013 drug manufacturing prices by a maximum of 5.8% in the private sector. This is below expectations, and in addition to the continued depreciation of the Rand, should be seen as an opportunity for local d ..."
The government drive to support local production and reduce the country's reliance on imports, in addition to global epidemiological and demographic trends, are all positive factors contributing to long-term growth in the pharmaceutical market. However, deep segregation between p ..."
Despite the Medicine Control Council (MCC)'s strong stance on refusing to grant compassionate access to an investigational drug targeting multi-drug resistant tuberculosis, in the face of a heavy disease burden and international pressure, which may ..."